There are 15,359 results relating to "Medicin Viagra-m"
Order by
|
Official Report
Meeting date:
10 March 2021
Meeting of the Parliament (Hybrid)10 March 2021
Motion agreed to, That the Parliament agrees that the University of St. Andrews (Degrees in Medicine and Dentistry) Bill be passed.
Questions and Answers
Date answered:
16 December 2015
S4W-28843
The Scottish Government and NHS Scotland jointly published in March 2015 the Polypharmacy Guidance which provides guidance for all clinicians on the review of long-term medicines, drawn from NICE, with specific advice on withdrawing medicines such as benzodiazepines and addressing the prescribing of antidepressants.
Questions and Answers
Date answered:
29 October 2015
S4W-27918
These pharmacists will be allocated caseloads of patients by GPs within the practices in which they will work to deliver continuity of care and to get the best possible health outcomes from their medicines. They will carry out medicines reviews and support patients in the management of their long term conditions.
Questions and Answers
Date answered:
6 August 2014
S4W-22083
This includes the specialism of emergency medicine, which has increased by 119.9% over the same period.
Questions and Answers
Date answered:
12 June 2014
S4W-21364
To ask the Scottish Government when the new Peer Approved Clinical System will be operational and whether the transitional arrangements will continue in its place and remain financially supported by the Rare Conditions Medicines Fund. Work is ongoing between the Scottish Government and NHS boards evaluating the financial implications of the new approach by the Scottish Medicines Consortium (SMC) and how the Rare Conditions Medicines Fund (RCMF) can best support an increase in SMC approvals under this new approach.
Questions and Answers
Date answered:
11 June 2014
S4W-21536
NHS boards are expected to follow HIS advice on technologies in the planning and provision of its services, and clinicians are expected to follow their professional judgement, working within the management structure of their boards. For medicines, the Scottish Medicines Consortium assesses all new medicines and makes recommendations for their use in NHS Scotland.
Questions and Answers
Date answered:
16 December 2013
S4W-18778
The Scottish Government’s approach to access to new medicines is clear from our response to the Scottish Parliaments Health and Sport Committee, we want to see improved access within the NHS in Scotland to newly licensed medicines that represent the best in therapeutic value and are cost effective.
Questions and Answers
Date answered:
13 December 2012
S4W-11435
The Patient and Public Involvement Group (PAPIG) has three public partners who are members of the Scottish Medicines Consortium and contribute to the decision making.
Questions and Answers
Date answered:
14 May 2012
S4W-07026
Where this advice clarifies that a new medicine is not accepted for routine use within NHSScotland, NHS boards are not expected to make it routinely available.
Questions and Answers
Date answered:
26 April 2012
S4W-06515
Individual Patient Treatment Requests (IPTRs) provide an opportunity for NHS boards to undertake local clinically-led consideration of medicines which the Scottish Medicines Consortium (SMC) has advised are not recommended for routine use.
